Older radiation techniques have shown to elevate the long-term risk of breast cancer, lung problems and cardiac issues due to the consequences of those treatment modalities. Even with advancements in photon-based techniques, it’s apparent that there’s still excess mortality risk or notable problems down the line in these areas. Proton therapy substantially reduces exposure to the heart, lung, breast and circulating immune cells and blood cells, even compared to the most advanced forms of photon therapy.
Treating Non-Hodgkin’s Lymphoma
Non-Hodgkin’s lymphoma most often appears after age 50 in the chest, abdomen, neck, stomach, kidney and salivary glands. In some cases, this is treated with chemotherapy alone. If the tumor is confined to a specific area or considered bulky, measuring larger than determined criteria based on type, then radiation is indicated.
Radiation for non-Hodgkin’s lymphoma is used definitively to cure the patient, not just relieve symptoms. Radiation therapy using proton therapy may be the preferred option when the cancer is located in the head and neck, mediastinum or abdomen. Often, we’re able to get the necessary dose to the tumor more comprehensively than with photon therapy and do so without providing unnecessary dosage to tissues located nearby. Getting the dosage to the exact spot makes sense.
Evaluating the Use of Proton Therapy